• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗中部结直肠癌患者 p53 基因外显子 5 和 6 突变的特征及预后价值。

Characterization and Prognostic Value of Mutations in Exons 5 and 6 of the p53 Gene in Patients with Colorectal Cancers in Central Iran.

机构信息

Faculty of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran.

出版信息

Gut Liver. 2013 May;7(3):295-302. doi: 10.5009/gnl.2013.7.3.295. Epub 2013 Apr 9.

DOI:10.5009/gnl.2013.7.3.295
PMID:23710310
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3661961/
Abstract

BACKGROUND/AIMS: We aimed to investigate the relation-ships among various mutations of the p53 gene and their protein products, histological characteristics, and disease prognosis of primary colorectal cancer in Isfahan, central Iran.

METHODS

Sixty-one patients with colorectal adenocarcinoma were enrolled in the study. Mutations of the p53 gene were detected by single-stranded conformation polymorphism and DNA sequencing. The protein stability was evaluated by immunohistochemistry. Patients were followed up to 48 months.

RESULTS

Twenty-one point mutations in exons 5 and 6 were detected in the tumor specimens of 14 patients (23%). Of those, 81% and 9.5% were missense and nonsense mutations, respectively. There were also two novel mutations in the intronic region between exons 5 and 6. In 11 mutated specimens, protein stability and protein accumulation were identified. There was a relationship between the type of mutation and protein accumulation in exons 5 and 6 of the p53 gene. The presence of the mutation was associated with an advanced stage of cancer (trend, p<0.009). Patients with mutated p53 genes had significantly lower survival rates than those with wild type p53 genes (p<0.01).

CONCLUSIONS

Mutations in exons 5 and 6 of the p53 gene are common genetic alterations in colorectal adenocarcinoma in central Iran and are associated with a poor prognosis of the disease.

摘要

背景/目的:我们旨在研究伊朗中部伊斯法罕原发性结直肠癌中 p53 基因的各种突变及其蛋白产物、组织学特征与疾病预后之间的关系。

方法

本研究纳入了 61 例结直肠腺癌患者。通过单链构象多态性和 DNA 测序检测 p53 基因突变。通过免疫组织化学评估蛋白质稳定性。对患者进行了 48 个月的随访。

结果

在 14 例患者(23%)的肿瘤标本中检测到外显子 5 和 6 中的 21 个点突变。其中,81%和 9.5%分别为错义突变和无义突变。在 5 和 6 外显子之间的内含子区还存在两个新的突变。在 11 个突变标本中,鉴定到了蛋白质稳定性和蛋白积累。p53 基因外显子 5 和 6 中的突变类型与蛋白积累之间存在关系。突变的存在与癌症的晚期阶段有关(趋势,p<0.009)。携带突变 p53 基因的患者的生存率明显低于携带野生型 p53 基因的患者(p<0.01)。

结论

伊朗中部结直肠腺癌中 p53 基因外显子 5 和 6 的突变是常见的遗传改变,与疾病预后不良相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed57/3661961/ed17f828bfad/gnl-7-295-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed57/3661961/b734fba51e26/gnl-7-295-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed57/3661961/ed17f828bfad/gnl-7-295-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed57/3661961/b734fba51e26/gnl-7-295-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed57/3661961/ed17f828bfad/gnl-7-295-g002.jpg

相似文献

1
Characterization and Prognostic Value of Mutations in Exons 5 and 6 of the p53 Gene in Patients with Colorectal Cancers in Central Iran.伊朗中部结直肠癌患者 p53 基因外显子 5 和 6 突变的特征及预后价值。
Gut Liver. 2013 May;7(3):295-302. doi: 10.5009/gnl.2013.7.3.295. Epub 2013 Apr 9.
2
p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.免疫组织化学染色未检测到的p53无效突变预示早期非小细胞肺癌预后不良。
Cancer Res. 1999 Nov 1;59(21):5572-7.
3
Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.p53基因第7和8外显子突变作为非小细胞肺癌患者预后不良的因素
Oncogene. 1998 May 14;16(19):2469-77. doi: 10.1038/sj.onc.1201776.
4
Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.原发性和转移性胰腺导管病变的分子病理学:散发性和家族性病变中p53、mdm-2和p21/WAF-1基因的突变及表达分析
Cancer. 1997 Feb 15;79(4):700-16.
5
p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment.乳腺癌中的p53基因突变与类固醇受体状态。临床病理相关性及预后评估。
Cancer. 1994 Apr 15;73(8):2147-56. doi: 10.1002/1097-0142(19940415)73:8<2147::aid-cncr2820730820>3.0.co;2-5.
6
Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.p53基因改变而非肿瘤内p53蛋白过表达或血清p53抗体是散发性结直肠癌的一个预后因素。
Int J Oncol. 2005 Jan;26(1):65-75.
7
P53 mutations in colorectal cancer assessed in both genomic DNA and cDNA as compared to the presence of p53 LOH.与p53杂合性缺失的存在情况相比,在基因组DNA和互补DNA中评估的结直肠癌中的P53突变。
Int J Oncol. 2002 Aug;21(2):409-15.
8
p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.p53和Ki-ras作为Dukes B期结直肠癌的预后因素。
Eur J Cancer. 2000 May;36(8):1008-15. doi: 10.1016/s0959-8049(00)00036-8.
9
Comparative survival analysis of p53 gene mutations and protein accumulation in colorectal cancer.结直肠癌中p53基因突变与蛋白积累的比较生存分析
Oncology. 1998 May-Jun;55(3):249-57. doi: 10.1159/000011859.
10
[p53 mutations and protein overexpression in primary colorectal cancer and its liver metastasis].原发性结直肠癌及其肝转移中的p53突变与蛋白过表达
Zhonghua Zhong Liu Za Zhi. 1999 Mar;21(2):114-8.

引用本文的文献

1
Association between Gene Mutations and Colorectal Cancer in the Iranian Population: A Systematic Review.伊朗人群中基因突变与结直肠癌的关联:一项系统综述。
Iran J Public Health. 2025 Feb;54(2):309-320.
2
Genetic and molecular origins of colorectal Cancer among the Iranians: an update.伊朗人群中结直肠癌的遗传和分子起源:最新进展
Diagn Pathol. 2018 Dec 22;13(1):97. doi: 10.1186/s13000-018-0774-0.
3
Colorectal cancer in iran: molecular epidemiology and screening strategies.伊朗的结直肠癌:分子流行病学与筛查策略

本文引用的文献

1
The dimensions of the CRC problem.CRC 问题的维度。
Best Pract Res Clin Gastroenterol. 2010 Aug;24(4):381-96. doi: 10.1016/j.bpg.2010.06.004.
2
Global patterns of cancer incidence and mortality rates and trends.全球癌症发病率、死亡率的分布格局及变化趋势。
Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1893-907. doi: 10.1158/1055-9965.EPI-10-0437. Epub 2010 Jul 20.
3
Colorectal cancer.结直肠癌。
J Cancer Epidemiol. 2015;2015:643020. doi: 10.1155/2015/643020. Epub 2015 Jan 15.
Lancet. 2010 Mar 20;375(9719):1030-47. doi: 10.1016/S0140-6736(10)60353-4.
4
Molecular origins of cancer: Molecular basis of colorectal cancer.癌症的分子起源:结直肠癌的分子基础
N Engl J Med. 2009 Dec 17;361(25):2449-60. doi: 10.1056/NEJMra0804588.
5
Epidemiology of colorectal cancer in Asia.亚洲结直肠癌的流行病学。
J Gastroenterol Hepatol. 2009 Dec;24(12):1810-6. doi: 10.1111/j.1440-1746.2009.06138.x.
6
Combination of p53 codon 72 polymorphism and inactive p53 mutation predicts chemosensitivity to 5-fluorouracil in colorectal cancer.p53 密码子 72 多态性与无活性 p53 突变的联合预测结直肠癌对氟尿嘧啶的化疗敏感性。
Int J Cancer. 2010 Apr 1;126(7):1691-701. doi: 10.1002/ijc.24929.
7
Overview of colorectal cancer genetics.结直肠癌遗传学概述。
Surg Oncol Clin N Am. 2009 Oct;18(4):573-83. doi: 10.1016/j.soc.2009.08.004.
8
Metalloproteinase-1, metalloproteinase-7, and p53 immunoexpression and their correlation with clinicopathological prognostic factors in colorectal adenocarcinoma.金属蛋白酶-1、金属蛋白酶-7 和 p53 的免疫表达及其与结直肠腺癌临床病理预后因素的相关性。
Int J Biol Markers. 2009 Jul-Sep;24(3):156-64. doi: 10.1177/172460080902400305.
9
A comparison of colon and rectal somatic DNA alterations.结肠和直肠体细胞DNA改变的比较。
Dis Colon Rectum. 2009 Jul;52(7):1304-11. doi: 10.1007/DCR.0b013e3181a0e5df.
10
P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.P53与表皮生长因子受体(EGFR)在结直肠癌中的表达:对长期随访患者“旧”组织标志物的重新评估
Anticancer Res. 2009 Feb;29(2):785-91.